Last update : 10/19/2017 | Version : 1 | ID : 73340
General | |
Identification | |
Detailed name | Observational study of the management of metastatic melanoma in France |
Sign or acronym | AMEL |
General Aspects | |
Medical area |
Cancer research |
Pathology (details) | metastatic melanoma |
Scientific investigator(s) (Contact) | |
Name of the director | Godard |
Surname | Chloé |
Address |
34 avenue Léonard de Vinci 92418 Courbevoie cedex |
chloe.godard@merck.com | |
Unit | MSD France |
Collaborations | |
Funding | |
Funding status |
Private |
Details | MSD France |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | MSD France |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database objective | |
Main objective | Describe the sociodemographic and clinical profile of patients with metastatic melanoma as well as their therapeutic management |
Inclusion criteria |
Inclusion criteria:
• History of histopathologically confirmed diagnosis of cutaneous melanoma • Unresectable stage III (per treating physician) or stage IV melanoma according to AJCC (2009) classification at diagnosis or upon progression following diagnosis • Subject’s index date is between 1 January 2012 and 31 October 2012. • Age >= 18 years at the index date • Access to the complete records from the index date until the end of the data extraction period or death whichever is earlier Non-inclusion criteria: • Patients with primary non-cutaneous melanoma including primary ocular melanoma • Patients with an index date before 1 January 2012 and 31 October 2012. • Patients with resectable melanoma who have not relapsed |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Pathology | C00-C97 - Malignant neoplasms |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | no information about the individual |
Data collection | |
Dates | |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 271 patients included |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Administrative data Cost data |
Clinical data (detail) |
Direct physical measures |
Presence of a biobank |
No |
Procedures | |
Participant monitoring |
No |
Followed pathology | |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | No data access charter |
Access to aggregated data |
Access not yet planned |
Access to individual data |
No access |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05